皮膚糸状菌症治療薬市場：治療法、製品、販売チャネル別-2025-2030年の世界予測

皮膚糸状菌症治療薬市場は、2023年に126億3,000万米ドルと評価され、2024年には133億3,000万米ドルに達すると予測され、CAGR 5.88％で成長し、2030年には188億5,000万米ドルに達すると予測されています。

皮膚糸状菌症治療薬は、世界のヘルスケア市場において、皮膚、毛髪、爪に影響を及ぼす真菌感染症を扱う重要なセグメントです。この市場には、幅広い種類の外用・全身用抗真菌薬や、レーザー治療、新興バイオテクノロジーソリューションなどの新規治療アプローチが含まれます。これらの治療の必要性は、湿度の高い環境、不衛生、免疫不全者の増加といった要因によって悪化した皮膚糸状菌感染症の世界の広範な発生に起因しています。これらの治療薬の用途は、市販品と処方箋に基づく製品の両方にまたがり、世界中の多様な消費者ニーズとヘルスケア政策に対応しています。最終用途の範囲には、病院、小売薬局、オンライン・プラットフォームが含まれ、広範かつ多様な市場範囲を反映しています。この市場に影響を与える主な成長要因としては、製剤の進歩、皮膚の健康に対する意識の高まり、ヘルスケアへのアクセスを容易にする可処分所得の増加などが挙げられます。さらに、治療効果の向上と副作用の最小化に焦点を当てた研究開発活動の活発化が、重要な機会をもたらしています。企業は技術革新に投資し、戦略的提携を結んで製品ポートフォリオと地理的プレゼンスを拡大することで、これらを活用することができます。しかし、薬剤耐性、既存治療の潜在的副作用、厳しい規制状況といった制約が、注目すべき課題となっています。新興国市場における経済的障壁は、代替医療や伝統的治療法との競合とともに、市場拡大をさらに制限しています。技術革新が必要な分野としては、バイオベースの抗真菌剤の開発、光線力学的療法、治療の精度を高めるための遺伝子プロファイリングを用いた個別化医療のアプローチなどが挙げられます。市場力学は、急速な技術進歩と消費者ニーズの進化を特徴とするダイナミックな市場であり、継続的な調査と機敏な事業戦略の重要性が強調されています。飛躍を目指す企業にとって、持続可能で患者中心の治療ソリューションに焦点を当て続けることは極めて重要です。

市場力学：急速に進化する皮膚糸状菌症治療薬市場の主要市場インサイトを公開

皮膚糸状菌症治療薬市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的意思決定、新たなビジネスチャンスの獲得を行うことができます。こうした動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができるとともに、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 人口における足白癬の著しい蔓延
  • 皮膚糸状菌症に対する意識の高まり
• 市場抑制要因
  • 製品回収に関連する大きな問題
• 市場機会
  • 新規抗真菌剤および新製剤に関する調査
  • オンライン販売チャネルを通じたOTC皮膚科学製品の入手可能性の拡大
• 市場の課題
  • 資本集約的で時間のかかる製品承認プロセス

ポーターのファイブフォース：皮膚糸状菌症治療薬市場をナビゲートする戦略ツール

ポーターのファイブフォースフレームワークは、市場情勢の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：皮膚糸状菌症治療薬市場における外部からの影響の把握

外部マクロ環境要因は、皮膚糸状菌症治療薬市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析皮膚糸状菌症治療薬市場における競合情勢の把握

皮膚糸状菌症治療薬市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的な意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックス皮膚糸状菌症治療薬市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、皮膚糸状菌症治療薬市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によってベンダーを明確かつ正確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨皮膚糸状菌症治療薬市場における成功への道筋を描く

皮膚糸状菌症治療薬市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を見直すことで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 人口における足白癬の有病率の高さ
    • 皮膚糸状菌症に対する意識の高まり
  • 抑制要因
    • 製品リコールに関連する重大な問題
  • 機会
    • 新しい抗真菌剤と新しい製剤に焦点を当てた調査
    • オンライン販売チャネルを通じてOTC皮膚科製品の入手可能性が増加
  • 課題
    • 資本集約的で時間のかかる製品承認プロセス
• 市場セグメンテーション分析

第5章 2.1.治療：

第5章 2.2.販売チャネル：

• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 皮膚糸状菌症治療薬市場治療別

• 併用療法
• 経口抗真菌薬
• 局所抗真菌薬
  • クリーム＆ローション
  • ゲル
  • 粉
  • スプレー

第7章 皮膚糸状菌症治療薬市場：製品別

• 市販薬（OTC）
• 処方薬

第8章 皮膚糸状菌症治療薬市場：販売チャネル別

• オフライン
  • 病院・クリニック
  • 小売薬局
• オンライン

第9章 南北アメリカの皮膚糸状菌症治療薬市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第10章 アジア太平洋地域の皮膚糸状菌症治療薬市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第11章 欧州・中東・アフリカの皮膚糸状菌症治療薬市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第12章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
  • バイエル、カネステン製品群の強化でインドにおける真菌感染症治療を向上
  • グレンマーク・ファーマシューティカルズ、インドで皮膚糸状菌症と闘うためIADVLと共同で「Hello Skin」チャットボットを導入
• 戦略分析と提言

企業一覧

• Abbott Laboratories
• Aetna Inc
• Alva-Amco Pharmacal Companies, Inc
• Aurobindo Pharma Limited
• Bausch Health Companies Inc.
• Bayer AG
• Blueberry Therapeutics Ltd.
• Cipla Ltd.
• Creative Biolabs
• Dr. Reddy's Laboratories Ltd.
• GlaxoSmithKline PLC
• Glenmark Pharmaceuticals Limited
• Ipca Laboratories Ltd
• Leeford Healthcare Ltd
• Mylan N.V.
• Novartis AG
• Oaknet Healthcare Pvt Ltd
• Perrigo Company PLC
• ProFoot, Inc.
• Quinnova Pharmaceuticals Inc.
• Sebela Pharmaceuticals Holdings Inc.
• Steris Healthcare PVT Ltd
• Sun Pharmaceutical Industries Ltd.
• Taisho Pharmaceutical Co., Ltd.
• Vibcare Pharma Pvt. Ltd.

LIST OF FIGURES

• FIGURE 1. DERMATOPHYTOSIS TREATMENT MARKET RESEARCH PROCESS
• FIGURE 2. DERMATOPHYTOSIS TREATMENT MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL DERMATOPHYTOSIS TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY SALES CHANNEL, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY SALES CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. AMERICAS DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 13. AMERICAS DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. UNITED STATES DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 15. UNITED STATES DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. ASIA-PACIFIC DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. ASIA-PACIFIC DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. EUROPE, MIDDLE EAST & AFRICA DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 19. EUROPE, MIDDLE EAST & AFRICA DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. DERMATOPHYTOSIS TREATMENT MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 21. DERMATOPHYTOSIS TREATMENT MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. DERMATOPHYTOSIS TREATMENT MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL DERMATOPHYTOSIS TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. DERMATOPHYTOSIS TREATMENT MARKET DYNAMICS
• TABLE 7. GLOBAL DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY COMBINATION THERAPIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY ORAL ANTIFUNGALS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TOPICAL ANTIFUNGALS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY CREAM & LOTION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY GEL, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY POWDER, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY SPRAY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TOPICAL ANTIFUNGALS, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY OVER-THE-COUNTER (OTC) DRUGS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY PRESCRIPTION DRUGS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY OFFLINE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 22. GLOBAL DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 23. GLOBAL DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 24. GLOBAL DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY ONLINE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 25. AMERICAS DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 26. AMERICAS DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TOPICAL ANTIFUNGALS, 2018-2030 (USD MILLION)
• TABLE 27. AMERICAS DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 28. AMERICAS DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
• TABLE 29. AMERICAS DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 30. AMERICAS DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 31. ARGENTINA DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 32. ARGENTINA DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TOPICAL ANTIFUNGALS, 2018-2030 (USD MILLION)
• TABLE 33. ARGENTINA DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 34. ARGENTINA DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
• TABLE 35. ARGENTINA DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 36. BRAZIL DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 37. BRAZIL DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TOPICAL ANTIFUNGALS, 2018-2030 (USD MILLION)
• TABLE 38. BRAZIL DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 39. BRAZIL DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
• TABLE 40. BRAZIL DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 41. CANADA DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 42. CANADA DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TOPICAL ANTIFUNGALS, 2018-2030 (USD MILLION)
• TABLE 43. CANADA DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 44. CANADA DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
• TABLE 45. CANADA DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 46. MEXICO DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 47. MEXICO DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TOPICAL ANTIFUNGALS, 2018-2030 (USD MILLION)
• TABLE 48. MEXICO DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 49. MEXICO DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
• TABLE 50. MEXICO DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 51. UNITED STATES DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 52. UNITED STATES DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TOPICAL ANTIFUNGALS, 2018-2030 (USD MILLION)
• TABLE 53. UNITED STATES DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 54. UNITED STATES DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
• TABLE 55. UNITED STATES DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 56. UNITED STATES DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 57. ASIA-PACIFIC DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 58. ASIA-PACIFIC DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TOPICAL ANTIFUNGALS, 2018-2030 (USD MILLION)
• TABLE 59. ASIA-PACIFIC DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 60. ASIA-PACIFIC DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
• TABLE 61. ASIA-PACIFIC DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 62. ASIA-PACIFIC DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 63. AUSTRALIA DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 64. AUSTRALIA DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TOPICAL ANTIFUNGALS, 2018-2030 (USD MILLION)
• TABLE 65. AUSTRALIA DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 66. AUSTRALIA DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
• TABLE 67. AUSTRALIA DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 68. CHINA DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 69. CHINA DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TOPICAL ANTIFUNGALS, 2018-2030 (USD MILLION)
• TABLE 70. CHINA DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 71. CHINA DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
• TABLE 72. CHINA DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 73. INDIA DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 74. INDIA DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TOPICAL ANTIFUNGALS, 2018-2030 (USD MILLION)
• TABLE 75. INDIA DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 76. INDIA DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
• TABLE 77. INDIA DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 78. INDONESIA DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 79. INDONESIA DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TOPICAL ANTIFUNGALS, 2018-2030 (USD MILLION)
• TABLE 80. INDONESIA DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 81. INDONESIA DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
• TABLE 82. INDONESIA DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 83. JAPAN DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 84. JAPAN DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TOPICAL ANTIFUNGALS, 2018-2030 (USD MILLION)
• TABLE 85. JAPAN DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 86. JAPAN DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
• TABLE 87. JAPAN DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 88. MALAYSIA DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 89. MALAYSIA DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TOPICAL ANTIFUNGALS, 2018-2030 (USD MILLION)
• TABLE 90. MALAYSIA DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 91. MALAYSIA DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
• TABLE 92. MALAYSIA DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 93. PHILIPPINES DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 94. PHILIPPINES DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TOPICAL ANTIFUNGALS, 2018-2030 (USD MILLION)
• TABLE 95. PHILIPPINES DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 96. PHILIPPINES DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
• TABLE 97. PHILIPPINES DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 98. SINGAPORE DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 99. SINGAPORE DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TOPICAL ANTIFUNGALS, 2018-2030 (USD MILLION)
• TABLE 100. SINGAPORE DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 101. SINGAPORE DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
• TABLE 102. SINGAPORE DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 103. SOUTH KOREA DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 104. SOUTH KOREA DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TOPICAL ANTIFUNGALS, 2018-2030 (USD MILLION)
• TABLE 105. SOUTH KOREA DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 106. SOUTH KOREA DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
• TABLE 107. SOUTH KOREA DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 108. TAIWAN DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 109. TAIWAN DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TOPICAL ANTIFUNGALS, 2018-2030 (USD MILLION)
• TABLE 110. TAIWAN DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 111. TAIWAN DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
• TABLE 112. TAIWAN DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 113. THAILAND DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 114. THAILAND DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TOPICAL ANTIFUNGALS, 2018-2030 (USD MILLION)
• TABLE 115. THAILAND DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 116. THAILAND DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
• TABLE 117. THAILAND DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 118. VIETNAM DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 119. VIETNAM DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TOPICAL ANTIFUNGALS, 2018-2030 (USD MILLION)
• TABLE 120. VIETNAM DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 121. VIETNAM DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
• TABLE 122. VIETNAM DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 123. EUROPE, MIDDLE EAST & AFRICA DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 124. EUROPE, MIDDLE EAST & AFRICA DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TOPICAL ANTIFUNGALS, 2018-2030 (USD MILLION)
• TABLE 125. EUROPE, MIDDLE EAST & AFRICA DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 126. EUROPE, MIDDLE EAST & AFRICA DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
• TABLE 127. EUROPE, MIDDLE EAST & AFRICA DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 128. EUROPE, MIDDLE EAST & AFRICA DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 129. DENMARK DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 130. DENMARK DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TOPICAL ANTIFUNGALS, 2018-2030 (USD MILLION)
• TABLE 131. DENMARK DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 132. DENMARK DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
• TABLE 133. DENMARK DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 134. EGYPT DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 135. EGYPT DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TOPICAL ANTIFUNGALS, 2018-2030 (USD MILLION)
• TABLE 136. EGYPT DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 137. EGYPT DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
• TABLE 138. EGYPT DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 139. FINLAND DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 140. FINLAND DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TOPICAL ANTIFUNGALS, 2018-2030 (USD MILLION)
• TABLE 141. FINLAND DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 142. FINLAND DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
• TABLE 143. FINLAND DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 144. FRANCE DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 145. FRANCE DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TOPICAL ANTIFUNGALS, 2018-2030 (USD MILLION)
• TABLE 146. FRANCE DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 147. FRANCE DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
• TABLE 148. FRANCE DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 149. GERMANY DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 150. GERMANY DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TOPICAL ANTIFUNGALS, 2018-2030 (USD MILLION)
• TABLE 151. GERMANY DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 152. GERMANY DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
• TABLE 153. GERMANY DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 154. ISRAEL DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 155. ISRAEL DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TOPICAL ANTIFUNGALS, 2018-2030 (USD MILLION)
• TABLE 156. ISRAEL DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 157. ISRAEL DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
• TABLE 158. ISRAEL DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 159. ITALY DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 160. ITALY DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TOPICAL ANTIFUNGALS, 2018-2030 (USD MILLION)
• TABLE 161. ITALY DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 162. ITALY DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
• TABLE 163. ITALY DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 164. NETHERLANDS DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 165. NETHERLANDS DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TOPICAL ANTIFUNGALS, 2018-2030 (USD MILLION)
• TABLE 166. NETHERLANDS DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 167. NETHERLANDS DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
• TABLE 168. NETHERLANDS DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 169. NIGERIA DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 170. NIGERIA DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TOPICAL ANTIFUNGALS, 2018-2030 (USD MILLION)
• TABLE 171. NIGERIA DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 172. NIGERIA DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
• TABLE 173. NIGERIA DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 174. NORWAY DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 175. NORWAY DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TOPICAL ANTIFUNGALS, 2018-2030 (USD MILLION)
• TABLE 176. NORWAY DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 177. NORWAY DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
• TABLE 178. NORWAY DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 179. POLAND DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 180. POLAND DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TOPICAL ANTIFUNGALS, 2018-2030 (USD MILLION)
• TABLE 181. POLAND DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 182. POLAND DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
• TABLE 183. POLAND DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 184. QATAR DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 185. QATAR DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TOPICAL ANTIFUNGALS, 2018-2030 (USD MILLION)
• TABLE 186. QATAR DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 187. QATAR DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
• TABLE 188. QATAR DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 189. RUSSIA DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 190. RUSSIA DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TOPICAL ANTIFUNGALS, 2018-2030 (USD MILLION)
• TABLE 191. RUSSIA DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 192. RUSSIA DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
• TABLE 193. RUSSIA DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 194. SAUDI ARABIA DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 195. SAUDI ARABIA DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TOPICAL ANTIFUNGALS, 2018-2030 (USD MILLION)
• TABLE 196. SAUDI ARABIA DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 197. SAUDI ARABIA DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
• TABLE 198. SAUDI ARABIA DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 199. SOUTH AFRICA DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 200. SOUTH AFRICA DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TOPICAL ANTIFUNGALS, 2018-2030 (USD MILLION)
• TABLE 201. SOUTH AFRICA DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 202. SOUTH AFRICA DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
• TABLE 203. SOUTH AFRICA DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 204. SPAIN DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 205. SPAIN DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TOPICAL ANTIFUNGALS, 2018-2030 (USD MILLION)
• TABLE 206. SPAIN DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 207. SPAIN DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
• TABLE 208. SPAIN DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 209. SWEDEN DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 210. SWEDEN DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TOPICAL ANTIFUNGALS, 2018-2030 (USD MILLION)
• TABLE 211. SWEDEN DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 212. SWEDEN DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
• TABLE 213. SWEDEN DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 214. SWITZERLAND DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 215. SWITZERLAND DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TOPICAL ANTIFUNGALS, 2018-2030 (USD MILLION)
• TABLE 216. SWITZERLAND DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 217. SWITZERLAND DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
• TABLE 218. SWITZERLAND DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 219. TURKEY DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 220. TURKEY DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TOPICAL ANTIFUNGALS, 2018-2030 (USD MILLION)
• TABLE 221. TURKEY DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 222. TURKEY DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
• TABLE 223. TURKEY DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 224. UNITED ARAB EMIRATES DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 225. UNITED ARAB EMIRATES DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TOPICAL ANTIFUNGALS, 2018-2030 (USD MILLION)
• TABLE 226. UNITED ARAB EMIRATES DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 227. UNITED ARAB EMIRATES DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
• TABLE 228. UNITED ARAB EMIRATES DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 229. UNITED KINGDOM DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 230. UNITED KINGDOM DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TOPICAL ANTIFUNGALS, 2018-2030 (USD MILLION)
• TABLE 231. UNITED KINGDOM DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 232. UNITED KINGDOM DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
• TABLE 233. UNITED KINGDOM DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 234. DERMATOPHYTOSIS TREATMENT MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 235. DERMATOPHYTOSIS TREATMENT MARKET, FPNV POSITIONING MATRIX, 2023

The Dermatophytosis Treatment Market was valued at USD 12.63 billion in 2023, expected to reach USD 13.33 billion in 2024, and is projected to grow at a CAGR of 5.88%, to USD 18.85 billion by 2030.

Dermatophytosis treatment is an imperative segment within the global healthcare market, addressing fungal infections affecting skin, hair, and nails. The scope of this market includes a wide range of topical and systemic antifungal medications and novel therapeutic approaches such as laser therapy and emerging biotech solutions. The necessity for these treatments stems from the widespread occurrence of dermatophytic infections globally, exacerbated by factors like humid environments, poor hygiene, and increasing rates of immunocompromised individuals. Applications of these treatments span across both over-the-counter and prescription-based products, catering to diverse consumer needs and healthcare policies worldwide. The end-use scope includes hospitals, retail pharmacies, and online platforms, reflecting a broad and versatile market reach. Key growth factors influencing this market include advancements in drug formulations, a rise in awareness about skin health, and an increase in disposable income facilitating access to healthcare. Moreover, heightened research and development activities, focused on enhancing treatment efficacy and minimizing side effects, present vital opportunities. Companies could capitalize on these by investing in innovation and forming strategic alliances to expand their product portfolio and geographical presence. However, limitations such as drug resistance, potential side effects of existing treatments, and stringent regulatory landscapes pose notable challenges. Economic barriers in developing regions further restrict market expansion, along with competition from alternative medicine and traditional remedies. Areas ripe for innovation include the development of bio-based antifungal agents, photodynamic therapy, and personalized medicine approaches using genetic profiling to enhance treatment precision. The nature of the dermatophytosis treatment market is dynamic, characterized by rapid technological advancements and evolving consumer needs, emphasizing the importance of continuous research and agile business strategies. For businesses looking to make significant strides, maintaining a focus on sustainable and patient-centric treatment solutions will be crucial.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Dermatophytosis Treatment Market

The Dermatophytosis Treatment Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Significant prevalence of tinea pedis among the population
  • Growing awareness about dermatophytosis disorders
• Market Restraints
  • Considerable issues associated with product recall
• Market Opportunities
  • Research focused on new antifungal agents and new formulations
  • Growing availability of OTC dermatological products through online sales channels
• Market Challenges
  • Capital-intensive and time-consuming product approval process

Porter's Five Forces: A Strategic Tool for Navigating the Dermatophytosis Treatment Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Dermatophytosis Treatment Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Dermatophytosis Treatment Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Dermatophytosis Treatment Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Dermatophytosis Treatment Market

A detailed market share analysis in the Dermatophytosis Treatment Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Dermatophytosis Treatment Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Dermatophytosis Treatment Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Dermatophytosis Treatment Market

A strategic analysis of the Dermatophytosis Treatment Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Dermatophytosis Treatment Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Aetna Inc, Alva-Amco Pharmacal Companies, Inc, Aurobindo Pharma Limited, Bausch Health Companies Inc., Bayer AG, Blueberry Therapeutics Ltd., Cipla Ltd., Creative Biolabs, Dr. Reddy's Laboratories Ltd., GlaxoSmithKline PLC, Glenmark Pharmaceuticals Limited, Ipca Laboratories Ltd, Leeford Healthcare Ltd, Mylan N.V., Novartis AG, Oaknet Healthcare Pvt Ltd, Perrigo Company PLC, ProFoot, Inc., Quinnova Pharmaceuticals Inc., Sebela Pharmaceuticals Holdings Inc., Steris Healthcare PVT Ltd, Sun Pharmaceutical Industries Ltd., Taisho Pharmaceutical Co., Ltd., and Vibcare Pharma Pvt. Ltd..

Market Segmentation & Coverage

This research report categorizes the Dermatophytosis Treatment Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Treatment, market is studied across Combination Therapies, Oral Antifungals, and Topical Antifungals. The Topical Antifungals is further studied across Cream & Lotion, Gel, Powder, and Spray.
• Based on Product, market is studied across Over-the-Counter (OTC) Drugs and Prescription Drugs.
• Based on Sales Channel, market is studied across Offline and Online. The Offline is further studied across Hospitals & Clinics and Retail Pharmacies.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Significant prevalence of tinea pedis among the population
    • 5.1.1.2. Growing awareness about dermatophytosis disorders
  • 5.1.2. Restraints
    • 5.1.2.1. Considerable issues associated with product recall
  • 5.1.3. Opportunities
    • 5.1.3.1. Research focused on new antifungal agents and new formulations
    • 5.1.3.2. Growing availability of OTC dermatological products through online sales channels
  • 5.1.4. Challenges
    • 5.1.4.1. Capital-intensive and time-consuming product approval process
• 5.2. Market Segmentation Analysis

5.2.1. Treatment:

5.2.2. Sales Channel:

• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Dermatophytosis Treatment Market, by Treatment

• 6.1. Introduction
• 6.2. Combination Therapies
• 6.3. Oral Antifungals
• 6.4. Topical Antifungals
  • 6.4.1. Cream & Lotion
  • 6.4.2. Gel
  • 6.4.3. Powder
  • 6.4.4. Spray

7. Dermatophytosis Treatment Market, by Product

• 7.1. Introduction
• 7.2. Over-the-Counter (OTC) Drugs
• 7.3. Prescription Drugs

8. Dermatophytosis Treatment Market, by Sales Channel

• 8.1. Introduction
• 8.2. Offline
  • 8.2.1. Hospitals & Clinics
  • 8.2.2. Retail Pharmacies
• 8.3. Online

9. Americas Dermatophytosis Treatment Market

• 9.1. Introduction
• 9.2. Argentina
• 9.3. Brazil
• 9.4. Canada
• 9.5. Mexico
• 9.6. United States

10. Asia-Pacific Dermatophytosis Treatment Market

• 10.1. Introduction
• 10.2. Australia
• 10.3. China
• 10.4. India
• 10.5. Indonesia
• 10.6. Japan
• 10.7. Malaysia
• 10.8. Philippines
• 10.9. Singapore
• 10.10. South Korea
• 10.11. Taiwan
• 10.12. Thailand
• 10.13. Vietnam

11. Europe, Middle East & Africa Dermatophytosis Treatment Market

• 11.1. Introduction
• 11.2. Denmark
• 11.3. Egypt
• 11.4. Finland
• 11.5. France
• 11.6. Germany
• 11.7. Israel
• 11.8. Italy
• 11.9. Netherlands
• 11.10. Nigeria
• 11.11. Norway
• 11.12. Poland
• 11.13. Qatar
• 11.14. Russia
• 11.15. Saudi Arabia
• 11.16. South Africa
• 11.17. Spain
• 11.18. Sweden
• 11.19. Switzerland
• 11.20. Turkey
• 11.21. United Arab Emirates
• 11.22. United Kingdom

12. Competitive Landscape

• 12.1. Market Share Analysis, 2023
• 12.2. FPNV Positioning Matrix, 2023
• 12.3. Competitive Scenario Analysis
  • 12.3.1. Bayer Elevates Fungal Infection Treatment in India with Enhanced Canesten Range
  • 12.3.2. Glenmark Pharmaceuticals Launches 'Hello Skin' Chatbot in Collaboration with IADVL to Combat Dermatophytosis in India
• 12.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Abbott Laboratories
• 2. Aetna Inc
• 3. Alva-Amco Pharmacal Companies, Inc
• 4. Aurobindo Pharma Limited
• 5. Bausch Health Companies Inc.
• 6. Bayer AG
• 7. Blueberry Therapeutics Ltd.
• 8. Cipla Ltd.
• 9. Creative Biolabs
• 10. Dr. Reddy's Laboratories Ltd.
• 11. GlaxoSmithKline PLC
• 12. Glenmark Pharmaceuticals Limited
• 13. Ipca Laboratories Ltd
• 14. Leeford Healthcare Ltd
• 15. Mylan N.V.
• 16. Novartis AG
• 17. Oaknet Healthcare Pvt Ltd
• 18. Perrigo Company PLC
• 19. ProFoot, Inc.
• 20. Quinnova Pharmaceuticals Inc.
• 21. Sebela Pharmaceuticals Holdings Inc.
• 22. Steris Healthcare PVT Ltd
• 23. Sun Pharmaceutical Industries Ltd.
• 24. Taisho Pharmaceutical Co., Ltd.
• 25. Vibcare Pharma Pvt. Ltd.